Ki16425
10mM in DMSO
- Product Code: 201429
CAS:
355025-24-0
| Molecular Weight: | 474.96 g./mol | Molecular Formula: | C₂₃H₂₃ClN₂O₅S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD06798341 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Ki16425 is a selective antagonist for the LPA1 receptor (lysophosphatidic acid receptor 1), making it a valuable tool in research focused on cellular signaling pathways mediated by lysophosphatidic acid (LPA). It is widely used in studies investigating fibrosis, cancer progression, and inflammatory diseases. By blocking LPA1, Ki16425 helps researchers understand the role of this receptor in processes such as cell migration, proliferation, and survival.
In pulmonary fibrosis models, Ki16425 has demonstrated the ability to reduce fibrotic responses by inhibiting fibroblast recruitment and activation. It is also applied in cancer research, where LPA signaling contributes to tumor invasion and metastasis, particularly in breast and ovarian cancers. Additionally, it has been used to probe LPA involvement in neuropathic pain and autoimmune conditions.
Due to its selectivity, Ki16425 allows for targeted modulation of LPA1 without significant off-target effects on other LPA receptor subtypes, enhancing its utility as a pharmacological probe in preclinical studies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿7,200.00 |
+
-
|
Ki16425
Ki16425 is a selective antagonist for the LPA1 receptor (lysophosphatidic acid receptor 1), making it a valuable tool in research focused on cellular signaling pathways mediated by lysophosphatidic acid (LPA). It is widely used in studies investigating fibrosis, cancer progression, and inflammatory diseases. By blocking LPA1, Ki16425 helps researchers understand the role of this receptor in processes such as cell migration, proliferation, and survival.
In pulmonary fibrosis models, Ki16425 has demonstrated the ability to reduce fibrotic responses by inhibiting fibroblast recruitment and activation. It is also applied in cancer research, where LPA signaling contributes to tumor invasion and metastasis, particularly in breast and ovarian cancers. Additionally, it has been used to probe LPA involvement in neuropathic pain and autoimmune conditions.
Due to its selectivity, Ki16425 allows for targeted modulation of LPA1 without significant off-target effects on other LPA receptor subtypes, enhancing its utility as a pharmacological probe in preclinical studies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :